Companies To Watch: Spinogenix - lifescienceleader.com
2024年10月18日 · By Ben Comer, Chief Editor, Life Science Leader. Stella Sarraf, Ph.D. Using small molecule drugs to restore synapses in neurological diseases. Snapshot. Los Angeles-based Spinogenix, a privately held small molecule drug discovery and development company, is currently testing two clinical candidates in four diseases: SPG302 in amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and ...
Life Science Leader - Home Page
Life Science Leader - thought leadership articles and discussions about the current life science industry
Quality Agreements In Clinical Development A Road Map Toward …
2014年12月24日 · <p>With clinical research continuing the trend of outsourcing more clinical trial activities to clinical service providers such as CROs or other vendors, it has become critical for sponsors to ensure that the activities they have outsourced are performed in accordance with the sponsor’s quality expectations. Because of shortened development timelines, often after a rigorous selection ...
Are Genetically Modified Organisms (GMO) A Blessing Or A Curse
2018年8月27日 · Back in March of this year, a reader of Life Science Leader magazine submitted the above question for our popular monthly Ask The Board column. Started in our February 2011 issue, the column enables readers to submit questions, which are then posed to a member of Life Science Leader’s editorial advisory board (EAB).Board members are asked to provide a 160-word written response, which is ...
Collecting Competitive Intelligence At Conferences - Life Science …
2019年11月1日 · By Arjan Singh. Conferences and trade shows are great places to learn about your competitive environment, as most companies in the industry usually attend these events; this includes competitors, suppliers, customers, and influencers.
Gaurav Shah — A Rare Disease Biopharma CEO Shares A Rare …
By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. Gaurav Shah, M.D., CEO of Rocket Pharmaceuticals, on the “Red Carpet” at the 2019 GRAMMY Award’s as a nominated artist.
A Glimpse Into David Lucchino Cofounder And CEO Of Frequency …
2020年9月21日 · By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. David Lucchino, cofounder and CEO, Frequency Therapeutics. It was roughly 18 years ago when David Lucchino, CEO and cofounder of Frequency Therapeutics (and subject of an upcoming feature in Life Science Leader), first had the opportunity to meet famed MIT professor, Robert Langer, Sc.D.
Mitigating Risks For Temperature Excursions When Shipping …
2010年9月15日 · <p> In the clinical supplies business, you need to be capable of handling and distributing the drug supply both domestically and internationally within very specific temperature ranges. The percentage of investigational drug supplies requiring specific temperature control is far greater than for approved drug products, due to limited stability data and the development of new molecules by the ...
Where Are They Now? SQZ Biotech - lifescienceleader.com
2024年5月1日 · By Ben Comer, Chief Editor, Life Science Leader. Armon Sharei. Then: In the March 2019 issue of Life Science Leader, SQZ Biotech cofounder and CEO Armon Sharei, Ph.D., reflected on his initial attraction to an MIT project led by Professor Klavs Jensen: delivering materials into cells using a microfluidic gun. “Imagine a miniaturized, high-powered squirt gun designed to fire things into cells ...
Using SharePoint In A Regulated Environment - Life Science Leader
2009年7月4日 · <p> The regulatory landscape is constantly changing and requires a greater number of businesses to demonstrate compliance. The compliance landscape for most organizations consists of either Sarbanes-Oxley (SOX), Health Insurance Portability and Accountability Act (HIPAA), or the FDA’s Code of Federal Regulations (CFR) 21 Part 11 regarding electronic records and electronic signatures.</p>